Title:
【発明の名称】インターロイキン変換酵素およびアポプトーシス
Document Type and Number:
Japanese Patent JPH11511463
Kind Code:
A
Abstract:
The present invention is to the novel compounds of Formula (I), their pharmaceutical compositions, and to the novel inhibition of ICE and ICE-like proteins for use in the treatment of apoptosis, and disease states caused by excessive or inappropriate cell death.
Inventors:
Levy, Mark Alan
Lee, Dennis
Gleason, John Gerald
Taylor, Andrew William
Corbert, david francis
Lee, Dennis
Gleason, John Gerald
Taylor, Andrew William
Corbert, david francis
Application Number:
JP51059097A
Publication Date:
October 05, 1999
Filing Date:
August 29, 1996
Export Citation:
Assignee:
SMITHKLINE BEECHAM CORPORATION
SmithKline Beecham Public Limited Company
SmithKline Beecham Public Limited Company
International Classes:
A61K31/00; A61K31/545; A61K31/546; A61P1/00; A61P1/16; A61P9/00; A61P9/10; A61P19/00; A61P19/02; A61P19/08; A61P25/28; A61P31/00; A61P31/12; A61P43/00; C07D501/00; (IPC1-7): C07D501/00; A61K31/00; A61K31/545
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)